岩間 英明

Medicine & Life Sciences

1. Pancreaticoduodenectomy 100%
2. Pancreatic Fistula 95%
3. Cathepsin B 94%
4. Hepatocellular Carcinoma 87%
5. Pancreatectomy 86%
6. Pancreas 82%
7. Robotics 75%
8. Lymphoma 73%
9. Cathepsin L 60%
10. Liver 56%
11. Lymphoma, Large B-Cell, Diffuse 54%
12. Hairy Cell Leukemia 49%
13. Touch 48%
14. Cathepsin D 47%
15. Hepatectomy 46%
16. Elasticity Imaging Techniques 44%
17. Drug Therapy 42%
18. Recurrence 41%
19. Hepatic Artery 41%
20. Chronic Pancreatitis 40%
21. Autophagy 39%
22. Jejunum 39%
23. Gastrectomy 37%
24. Peritonitis 37%
25. Trypsin 37%
26. Paclitaxel 36%
27. Ascites 35%
28. B-Cell Chronic Lymphocytic Leukemia 35%
29. Pancreatitis 35%
30. Surgical Instruments 35%
31. Elasticity 34%
32. Knockout Mice 33%
33. Immunoglobulin D 31%
34. Stomach Neoplasms 31%
35. Survival 29%
36. Pathologic Constriction 28%
37. Adenocarcinoma 28%
38. Ultrasonography 28%
39. Gastric Bypass 27%
40. Outpatients 27%
41. Acinar Cells 25%
42. Light 25%
43. Cyclin D1 25%
44. Tomography 24%
45. Splenic Artery 24%
46. Hemorrhage 23%
47. Neoplasms 22%
48. Ceruletide 21%
49. Immunoglobulin M 20%
50. Rituximab 19%